Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: Results from an exploratory randomized controlled trial

Inflammatory Bowel Diseases

Volumn 17, Issue 9, 2011, Pages 1874-1881

  Moshkovska, Tetyana ^a   Stone, Margaret A ^b   Smith, Roger M ^c   Bankart, John ^b   Baker, Richard ^b   Mayberry, John F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

5 aminosalicylic acid; adherence enhancing interventions; medication adherence; persistence with therapy; ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; BALSALAZIDE; MESALAZINE; MESREN; SALAZOSULFAPYRIDINE; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HEALTH BELIEF; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MOTIVATION; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT PREFERENCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SENSITIVITY ANALYSIS; ULCERATIVE COLITIS; UNITED KINGDOM; VALIDATION PROCESS;

EID: 80051534822     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21570     Document Type: Article

References (37)

1. Shale MJ, Riley SA,. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2003; 18: 191-198. (Pubitemid 36951655)
2. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001; 96: 2929-2933. (Pubitemid 32959535)
3. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003; 114: 39-43. (Pubitemid 36126514)
4. Higgins PD, Rubin DT, Kaulback K, et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009; 29: 247-257.
5. Sutherland LR, MacDonald JK,. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2006; 2: CD000544.
6. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000; 14: 145-153. (Pubitemid 30088290)
7. Rubin DT, LoSavio A, Yadron N, et al. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006; 4: 1346-1350. (Pubitemid 44716744)
8. Velayos FS, Terdiman JP, Walsh JM,. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2005; 100: 1345-1353. (Pubitemid 40904360)
9. van Staa TP, Card T, Logan RF, et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005; 54: 1573-1578. (Pubitemid 41531774)
10. Kane S, Accort N, Magowan S, et al. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis. Aliment Pharmacol Ther. 2009; 29: 855-862.
11. Peterson AM, Takiya L, Finley R,. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003; 60: 657-665. (Pubitemid 36752868)
12. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database System Rev. 2008: CD000011.
13. Elliott RA, Barber N, Horne R,. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother. 2005; 39: 508-515. (Pubitemid 40270917)
14. Marinker M, Shaw J,. Not to be taken as directed. Putting concordance for taking medicines into practice. BMJ. 2003; 326: 348-349.
15. Nichols-English G, Poirier S,. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assos. 2000; 40: 475-485.
16. Kane S, Sumner M, Solomon D, et al. Factors affecting persistence with mesalamine therapy: results from a large pharmacy database. Am J Gastroenterol. 2009; 104 (suppl 3): A1272.
17. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998; 36: 1138-1161. (Pubitemid 128456406)
18. Haynes RB, McDonald H, Garg AX, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002; CD000011.
19. Horne R, Weinman J, Barber N, et al. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO), London 2005.
20. Waters BM, Jensen L, Fedorak RN,. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol. 2005; 19: 235-244. (Pubitemid 40778865)
21. Fulmer TT, Feldman PH, Kim TS, et al. An intervention study to enhance medication compliance in community-dwelling elderly individuals. J Gerontol Nurs. 1999; 25: 6-14.
22. Ludlow H, Hurley J, Dolwani S,. Using email and text messaging to remind patients to have blood monitoring test. Nurs Times. 2009; 105: 26-28.
23. Kalichman SC, Cain D, Cherry C, et al. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care Stds. 2005; 19: 833-839. (Pubitemid 43100338)
24. Gould ON, Todd L, Irvine-Meek J,. Adherence devices in a community sample: How are pillboxes used? Can Pharm J. 2009; 142: 28-35.
25. Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structure model analysis. Clin Infect Dis. 2007; 45: 908-915. (Pubitemid 47580387)
26. Rowlinson A,. Inflammatory bowel disease. 3: Importance of partnership in care. Br J Nurs. 1999; 8: 1013-1018.
27. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000; 321: 694-696.
28. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008; 337: 979-983.
29. Horne R, Weinman J,. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47: 555-567. (Pubitemid 30029305)
30. Horne R, Hankins M, Jenkins R,. The Satisfaction with Information about Medicines Scale (SIMS); a new measurement tool for audit and research. Qual Saf Health Care. 2001; 10: 135-140.
31. Moshkovska T, Stone M, Baker R, et al. Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis. Inflamm Bowel Dis. 2008; 14: 763-768. (Pubitemid 351898060)
32. Horne R,. Treatment perceptions and self regulation. In:, Cameron LD, Leventhal H, eds. The Self-Regulation of Health and Illness Behaviour. London: Routledge Taylor & Francis Group; 2003. p 138-153.
33. Moshkovska T, Stone MA, Clatworthy J, et al. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements. Aliment Pharmacol Ther. 2009; 30: 1118-1127.
34. Horne R,. Adherence to medication: a review of existing research. In:, Myers L, Midence K, eds. Adherence to Treatment in Medical Conditions. London: Harwood Academic Press; 1998. p 285-310.
35. Kripalani S, Yao X, Haynes RB,. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007; 167: 540-550. (Pubitemid 46513223)
36. Kennedy AP, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004; 53: 1639-1645. (Pubitemid 39434108)
37. Gray J, Leung E, Scales J,. Treatment of ulcerative colitis from the patient's perspectives: a survey of preferences and satisfactions with therapy. Aliment Pharmacol Ther. 2009; 29: 1114-1120.